| Literature DB >> 32451384 |
Marcia de Almeida Monteiro Melo Ferraz1, Mayako Fujihara2, Jennifer Beth Nagashima3, Michael James Noonan3, Miho Inoue-Murayama2,4, Nucharin Songsasen3.
Abstract
Extracellular vesicles (EVs) contain multiple factors that regulate cell and tissue function. However, understanding of their influence on gametes, including communication with the oocyte, remains limited. In the present study, we characterized the proteome of domestic cat (Felis catus) follicular fluid EVs (ffEV). To determine the influence of follicular fluid EVs on gamete cryosurvival and the ability to undergo in vitro maturation, cat oocytes were vitrified using the Cryotop method in the presence or absence of ffEV. Vitrified oocytes were thawed with or without ffEVs, assessed for survival, in vitro cultured for 26 hours and then evaluated for viability and meiotic status. Cat ffEVs had an average size of 129.3 ± 61.7 nm (mean ± SD) and characteristic doughnut shaped circular vesicles in transmission electron microscopy. Proteomic analyses of the ffEVs identified a total of 674 protein groups out of 1,974 proteins, which were classified as being involved in regulation of oxidative phosphorylation, extracellular matrix formation, oocyte meiosis, cholesterol metabolism, glycolysis/gluconeogenesis, and MAPK, PI3K-AKT, HIPPO and calcium signaling pathways. Furthermore, several chaperone proteins associated with the responses to osmotic and thermal stresses were also identified. There were no differences in the oocyte survival among fresh and vitrified oocyte; however, the addition of ffEVs to vitrification and/or thawing media enhanced the ability of frozen-thawed oocytes to resume meiosis. In summary, this study is the first to characterize protein content of cat ffEVs and their potential roles in sustaining meiotic competence of cryopreserved oocytes.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32451384 PMCID: PMC7248092 DOI: 10.1038/s41598-020-65497-w
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Follicular fluid EVs characterization. In a size distribution of ffEVs quantified by nanoparticle tracking analysis (NTA, orange, left y axis), and analyzed by transmission electron microscopy (TEM, in percentage of total counted ffEVs, blue, right y axis). In b and c TEM image of ffEVs showing different size distribution of isolated ffEVs.
Selected gene ontology (GO) terms for biological processes of ffEVs, including significance (Group P-value) and the percentage of associated genes.
| GO ID | GO Term | Group P-value | % Associated Genes |
|---|---|---|---|
| GO:0051276 | chromosome organization | 0.00 | 8.29 |
| GO:0051293 | establishment of spindle localization | 0.00 | 20.00 |
| GO:0051653 | spindle localization | 0.00 | 17.14 |
| GO:0006997 | nucleus organization | 0.02 | 8.75 |
| GO:0007051 | spindle organization | 0.01 | 8.26 |
| GO:0000212 | meiotic spindle organization | 0.04 | 20.00 |
| GO:0051294 | establishment of spindle orientation | 0.05 | 12.00 |
| GO:0007010 | cytoskeleton organization | 0.00 | 6.69 |
| GO:0030036 | actin cytoskeleton organization | 0.00 | 7.42 |
| GO:0007015 | actin filament organization | 0.00 | 8.80 |
| GO:0030029 | actin filament-based process | 0.00 | 6.84 |
| GO:0031032 | actomyosin structure organization | 0.00 | 10.40 |
| GO:0061572 | actin filament bundle organization | 0.01 | 8.25 |
| GO:0051017 | actin filament bundle assembly | 0.01 | 8.25 |
| GO:0000226 | microtubule cytoskeleton organization | 0.04 | 5.31 |
| GO:0031032 | actomyosin structure organization | 0.00 | 10.40 |
| GO:0031122 | cytoplasmic microtubule organization | 0.04 | 9.76 |
| GO:0030865 | cortical cytoskeleton organization | 0.02 | 12.12 |
| GO:0030866 | cortical actin cytoskeleton organization | 0.02 | 10.34 |
| GO:0032964 | collagen biosynthetic process | 0.02 | 25.00 |
| GO:0032963 | collagen metabolic process | 0.02 | 13.51 |
| GO:0032965 | regulation of collagen biosynthetic process | 0.05 | 18.18 |
| GO:0010898 | positive regulation of triglyceride catabolic process | 0.02 | 40.00 |
| GO:0010873 | positive regulation of cholesterol esterification | 0.02 | 33.33 |
| GO:0010896 | regulation of triglyceride catabolic process | 0.02 | 28.57 |
| GO:0051006 | positive regulation of lipoprotein lipase activity | 0.02 | 28.57 |
| GO:0045723 | positive regulation of fatty acid biosynthetic process | 0.02 | 28.57 |
| GO:0034370 | triglyceride-rich lipoprotein particle remodeling | 0.02 | 25.00 |
| GO:0034380 | high-density lipoprotein particle assembly | 0.02 | 25.00 |
| GO:0034372 | very-low-density lipoprotein particle remodeling | 0.02 | 25.00 |
| GO:0010872 | regulation of cholesterol esterification | 0.02 | 25.00 |
| GO:0061365 | positive regulation of triglyceride lipase activity | 0.02 | 25.00 |
| GO:0033700 | phospholipid efflux | 0.02 | 20.00 |
| GO:0034433 | steroid esterification | 0.02 | 18.18 |
| GO:0051004 | regulation of lipoprotein lipase activity | 0.02 | 18.18 |
| GO:0034434 | sterol esterification | 0.02 | 18.18 |
| GO:0034435 | cholesterol esterification | 0.02 | 18.18 |
| GO:0043691 | reverse cholesterol transport | 0.02 | 18.18 |
| GO:0090208 | positive regulation of triglyceride metabolic process | 0.02 | 16.67 |
| GO:0044241 | lipid digestion | 0.02 | 14.29 |
| GO:0098609 | cell-cell adhesion | 0.00 | 6.30 |
| GO:0034109 | homotypic cell-cell adhesion | 0.00 | 21.43 |
| GO:0090136 | epithelial cell-cell adhesion | 0.01 | 25.00 |
| GO:0061077 | chaperone-mediated protein folding | 0.00 | 21.05 |
| GO:0016485 | protein processing | 0.00 | 10.06 |
| GO:0051604 | protein maturation | 0.00 | 9.55 |
| GO:0006956 | complement activation | 0.00 | 29.41 |
| GO:0072376 | protein activation cascade | 0.00 | 40.00 |
| GO:0015671 | oxygen transport | 0.00 | 44.44 |
| GO:0045454 | cell redox homeostasis | 0.00 | 14.04 |
| GO:1902883 | negative regulation of response to oxidative stress | 0.01 | 15.38 |
| GO:1900408 | negative regulation of cellular response to oxidative stress | 0.01 | 15.38 |
| GO:0080134 | regulation of response to stress | 0.00 | 5.42 |
| GO:0034976 | response to endoplasmic reticulum stress | 0.00 | 8.38 |
Figure 2KEGG molecular pathways performed by KEGG mapper (http://www.genome.jp/ kegg/mapper)[59] and GO protein class of ffEVs identified proteins. In a, KEGG pathways related to ECM-receptor interaction. Note that proteins present in ffEVs are shown in red. In b, pie chart of the 24 different GO protein classes corresponding to the proteins present in the cat ffEVs.
Figure 3Representative ovarian follicle with COC, summarizing oocyte cytoplasmic and nuclear maturation steps and participating proteins that could be delivered by ffEVs. PB = polar body, TJ = tight junction, GJ = gap junction, ECM = extracellular matrix.
Figure 4COCs uptake of ffEVs. In a, BODIPY labeled ffEVs uptake was evaluated before (0 hr), or following 0.25 h, 0.5 h, 1 h, or 18 h co-incubation with COCs. Fluorescence image in a showing uptake of ffEVs by the cumulus cells in a time dependent manner. In b, transfer of lipid (DiO) and membrane-bound protein (GD) labeled ffEVs to COCs after 1 or 18 h incubation. Bars = 100 and 25 µm for a and b panels, respectively.
Figure 5In a, survival rate of non-vitrified (Control) and vitrified oocytes in the presence or absence of ffEVs. Data is present as mean ± SD. In b a normal surviving oocyte and in c a non-surviving oocyte. Bars = 100 µm.
Figure 6Oocyte maturation stages of non-vitrified (Control) and vitrified COCs (Vitri), in the presence (+EV) or absence (-EV) of ffEVs, detected at 26 h. Bellow each stage in the graph are the corresponding representative images of the progression of oocyte meiotic stages with chromatin content (Hoechst 33342, blue) and tubulin (green). From left to right are germinal vesicle (GV), germinal vesicle breakdown (GV breakdown), initial chromosome alignment, stable chromosome alignment, polar body abscission, metaphase II (MII) and degeneration. No significant differences were noted between controls and vitrified oocytes (Friedman non-parametric analysis of variance, p > 0.05), regardless of the presence of ffEVs previously to or during thawing.
Figure 7Activation of meiotic resumption plot of vitrified oocytes in the absence (Vitri no EV) or presence of ffEVs (Vitri + EV) through the experimental time point. Note the higher initiation of oocyte maturation in the Vitri +EV group (ChiSquare, p = 0.0033). GVB, germinal vesicle breakdown; ICA, Innitial chromosome alignment; SCA, Stable chromosome alignment; PBA, Polar body abscission; MII, Metaphase II.
Figure 8Experimental design of ffEVs-COCs incubation, vitrification and thawing. Number written in each group indicates the number of oocytes used for vitrification/maturation experiments.